메뉴 건너뛰기




Volumn 59, Issue 6, 2003, Pages 471-474

Effect of doxercalciferol (1α-hydroxyvitamin D2) on PTH, bone turnover and bone mineral density in a hemodialysis patient with persistent secondary hyperparathyroidism post parathyroidectomy

Author keywords

Bone mineral density; Bone turnover; Doxercalciferol; Hemodialysis

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; COLLAGEN TYPE 1; DOXERCALCIFEROL; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; PHOSPHORUS; VITAMIN D DERIVATIVE; 1 ALPHA HYDROXYERGOCALCIFEROL; 1 ALPHA-HYDROXYERGOCALCIFEROL; ERGOCALCIFEROL;

EID: 0038715733     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp59471     Document Type: Article
Times cited : (4)

References (8)
  • 1
    • 0027930274 scopus 로고
    • Age-dependence of the normal/abnormal difference of bone mineral density in osteoporotic women
    • Bagur A, Vega E, Mautalen C 1994 Age-dependence of the normal/abnormal difference of bone mineral density in osteoporotic women. Bone Minerals 26: 209-218
    • (1994) Bone Minerals , vol.26 , pp. 209-218
    • Bagur, A.1    Vega, E.2    Mautalen, C.3
  • 3
    • 0031637872 scopus 로고    scopus 로고
    • 2 is effective and safe for the suppression of secondary hyperparathyroidism in hemodialysis patients
    • 2 Study Group
    • 2 is effective and safe for the suppression of secondary hyperparathyroidism in hemodialysis patients. Nephrol Dial Transplant 13: 68-72
    • (1998) Nephrol. Dial. Transplant , vol.13 , pp. 68-72
    • Frazao, J.M.1    Chesney, R.W.2    Coburn, J.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.